

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.08886184 |
| 2 | negative regulation of gluconeogenesis (GO:0045721) | 5.59460693 |
| 3 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.47418026 |
| 4 | neuron cell-cell adhesion (GO:0007158) | 5.44129791 |
| 5 | regulation of glucokinase activity (GO:0033131) | 5.43090552 |
| 6 | regulation of hexokinase activity (GO:1903299) | 5.43090552 |
| 7 | positive regulation of respiratory burst (GO:0060267) | 5.36255349 |
| 8 | glutamate secretion (GO:0014047) | 5.26650308 |
| 9 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 5.24137262 |
| 10 | positive regulation of glycolytic process (GO:0045821) | 5.18169329 |
| 11 | endocrine pancreas development (GO:0031018) | 5.08907039 |
| 12 | synaptic vesicle maturation (GO:0016188) | 5.07318303 |
| 13 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 5.06883270 |
| 14 | synaptic vesicle exocytosis (GO:0016079) | 4.91745579 |
| 15 | negative regulation of glycogen metabolic process (GO:0070874) | 4.85040914 |
| 16 | protein localization to synapse (GO:0035418) | 4.82919608 |
| 17 | vocalization behavior (GO:0071625) | 4.80051993 |
| 18 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.74495325 |
| 19 | negative regulation of protein oligomerization (GO:0032460) | 4.74401160 |
| 20 | layer formation in cerebral cortex (GO:0021819) | 4.68151721 |
| 21 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.66735872 |
| 22 | neuron recognition (GO:0008038) | 4.62251663 |
| 23 | negative regulation of hormone biosynthetic process (GO:0032353) | 4.50751151 |
| 24 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.45891842 |
| 25 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.34341509 |
| 26 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.32621036 |
| 27 | nitric oxide mediated signal transduction (GO:0007263) | 4.30207193 |
| 28 | chemosensory behavior (GO:0007635) | 4.25513716 |
| 29 | neuronal action potential propagation (GO:0019227) | 4.24910887 |
| 30 | insulin secretion (GO:0030073) | 4.22469573 |
| 31 | positive regulation of action potential (GO:0045760) | 4.22439639 |
| 32 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.18518337 |
| 33 | proline transport (GO:0015824) | 4.18223014 |
| 34 | locomotory exploration behavior (GO:0035641) | 4.16868083 |
| 35 | fatty acid homeostasis (GO:0055089) | 4.11353110 |
| 36 | cell migration in hindbrain (GO:0021535) | 4.09657478 |
| 37 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.09290376 |
| 38 | regulation of synaptic vesicle transport (GO:1902803) | 4.08872198 |
| 39 | lactate metabolic process (GO:0006089) | 4.05228145 |
| 40 | neurotransmitter secretion (GO:0007269) | 4.04895090 |
| 41 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.94896394 |
| 42 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.94580474 |
| 43 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.89724476 |
| 44 | axonal fasciculation (GO:0007413) | 3.86472275 |
| 45 | regulation of feeding behavior (GO:0060259) | 3.84573008 |
| 46 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.83346817 |
| 47 | activation of protein kinase A activity (GO:0034199) | 3.82433082 |
| 48 | negative regulation of hormone metabolic process (GO:0032351) | 3.78913718 |
| 49 | nucleoside diphosphate catabolic process (GO:0009134) | 3.78752188 |
| 50 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.77655255 |
| 51 | exploration behavior (GO:0035640) | 3.76950988 |
| 52 | type B pancreatic cell development (GO:0003323) | 3.74767172 |
| 53 | presynaptic membrane assembly (GO:0097105) | 3.73222250 |
| 54 | postsynaptic membrane organization (GO:0001941) | 3.71868695 |
| 55 | negative regulation of microtubule polymerization (GO:0031115) | 3.71590913 |
| 56 | regulation of glucocorticoid secretion (GO:2000849) | 3.70994465 |
| 57 | neuromuscular process controlling posture (GO:0050884) | 3.69744787 |
| 58 | positive regulation of glycogen biosynthetic process (GO:0045725) | 3.69661070 |
| 59 | long-term memory (GO:0007616) | 3.69281215 |
| 60 | dendritic spine morphogenesis (GO:0060997) | 3.64836465 |
| 61 | detection of calcium ion (GO:0005513) | 3.64727110 |
| 62 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.64169265 |
| 63 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.61973032 |
| 64 | glutamate receptor signaling pathway (GO:0007215) | 3.60220897 |
| 65 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.57323063 |
| 66 | negative regulation of catecholamine secretion (GO:0033604) | 3.52009298 |
| 67 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.46828386 |
| 68 | positive regulation of insulin secretion (GO:0032024) | 3.45980444 |
| 69 | cellular ketone body metabolic process (GO:0046950) | 3.43804445 |
| 70 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.43183624 |
| 71 | neurotransmitter transport (GO:0006836) | 3.42852378 |
| 72 | * positive regulation of peptide hormone secretion (GO:0090277) | 3.42405257 |
| 73 | nucleobase catabolic process (GO:0046113) | 3.42276394 |
| 74 | axon extension (GO:0048675) | 3.41982977 |
| 75 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.39696753 |
| 76 | presynaptic membrane organization (GO:0097090) | 3.39552721 |
| 77 | neuron-neuron synaptic transmission (GO:0007270) | 3.37744042 |
| 78 | tachykinin receptor signaling pathway (GO:0007217) | 3.37687379 |
| 79 | dendrite morphogenesis (GO:0048813) | 3.36427097 |
| 80 | positive regulation of synapse assembly (GO:0051965) | 3.36400132 |
| 81 | neuronal ion channel clustering (GO:0045161) | 3.35458288 |
| 82 | positive regulation of glycogen metabolic process (GO:0070875) | 3.34802082 |
| 83 | synaptic transmission, glutamatergic (GO:0035249) | 3.34061986 |
| 84 | transmission of nerve impulse (GO:0019226) | 3.33963914 |
| 85 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.33250791 |
| 86 | regulation of synapse structural plasticity (GO:0051823) | 3.32580045 |
| 87 | positive regulation of neurotransmitter transport (GO:0051590) | 3.31138518 |
| 88 | regulation of protein kinase A signaling (GO:0010738) | 3.31051585 |
| 89 | gamma-aminobutyric acid transport (GO:0015812) | 3.31046651 |
| 90 | * positive regulation of peptide secretion (GO:0002793) | 3.30608612 |
| 91 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.28190287 |
| 92 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.28169595 |
| 93 | regulation of vesicle fusion (GO:0031338) | 3.27364262 |
| 94 | synaptic vesicle endocytosis (GO:0048488) | 3.27048101 |
| 95 | behavioral response to nicotine (GO:0035095) | 3.25359642 |
| 96 | response to histamine (GO:0034776) | 3.22763296 |
| 97 | innervation (GO:0060384) | 3.22446798 |
| 98 | mating behavior (GO:0007617) | 3.21376420 |
| 99 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.20231572 |
| 100 | regulation of insulin secretion (GO:0050796) | 3.18973469 |
| 101 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.17586943 |
| 102 | positive regulation of protein autophosphorylation (GO:0031954) | 3.17586423 |
| 103 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.17269713 |
| 104 | regulation of neurotransmitter levels (GO:0001505) | 3.16855883 |
| 105 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.16138829 |
| 106 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.16138829 |
| 107 | synapse assembly (GO:0007416) | 3.14983416 |
| 108 | regulation of action potential (GO:0098900) | 3.13631044 |
| 109 | inositol phosphate catabolic process (GO:0071545) | 3.13507118 |
| 110 | cerebellar granule cell differentiation (GO:0021707) | 3.11747588 |
| 111 | cellular potassium ion homeostasis (GO:0030007) | 3.09401330 |
| 112 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.07647153 |
| 113 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.07574057 |
| 114 | glandular epithelial cell differentiation (GO:0002067) | 3.05090453 |
| 115 | peptide hormone secretion (GO:0030072) | 3.04045813 |
| 116 | ketone body metabolic process (GO:1902224) | 3.03949501 |
| 117 | regulation of respiratory system process (GO:0044065) | 3.03167684 |
| 118 | * regulation of postsynaptic membrane potential (GO:0060078) | 3.03081868 |
| 119 | regulation of neurotransmitter secretion (GO:0046928) | 3.02716122 |
| 120 | righting reflex (GO:0060013) | 3.02200006 |
| 121 | response to auditory stimulus (GO:0010996) | 3.01563313 |
| 122 | regulation of corticosteroid hormone secretion (GO:2000846) | 3.01437455 |
| 123 | calcium ion-dependent exocytosis (GO:0017156) | 3.00231254 |
| 124 | neuron projection extension (GO:1990138) | 2.99631421 |
| 125 | auditory behavior (GO:0031223) | 2.99147693 |
| 126 | membrane depolarization during action potential (GO:0086010) | 2.98484571 |
| 127 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.97929531 |
| 128 | dendrite development (GO:0016358) | 2.96216593 |
| 129 | regulation of synapse assembly (GO:0051963) | 2.95782283 |
| 130 | opioid receptor signaling pathway (GO:0038003) | 2.95046079 |
| 131 | neuromuscular process controlling balance (GO:0050885) | 2.94332315 |
| 132 | axon cargo transport (GO:0008088) | 2.94071550 |
| 133 | positive regulation of membrane potential (GO:0045838) | 2.93697166 |
| 134 | detection of temperature stimulus (GO:0016048) | 2.93300710 |
| 135 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.92799992 |
| 136 | negative regulation of heart rate (GO:0010459) | 2.92313995 |
| 137 | organelle transport along microtubule (GO:0072384) | 2.92022070 |
| 138 | peptide secretion (GO:0002790) | 2.91513154 |
| 139 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.91148377 |
| 140 | learning (GO:0007612) | 2.90963179 |
| 141 | positive regulation of synapse maturation (GO:0090129) | 2.89455401 |
| 142 | startle response (GO:0001964) | 2.88791610 |
| 143 | glycerophospholipid catabolic process (GO:0046475) | 2.87073140 |
| 144 | * regulation of peptide hormone secretion (GO:0090276) | 2.85648286 |
| 145 | negative regulation of neurological system process (GO:0031645) | 2.79761883 |
| 146 | * regulation of peptide secretion (GO:0002791) | 2.79213561 |
| 147 | brain morphogenesis (GO:0048854) | 2.77289747 |
| 148 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.76708814 |
| 149 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.76708814 |
| 150 | dentate gyrus development (GO:0021542) | 2.76543361 |
| 151 | cellular response to leptin stimulus (GO:0044320) | 2.76529877 |
| 152 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.76120214 |
| 153 | calcium ion import (GO:0070509) | 2.73537908 |
| 154 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.72347360 |
| 155 | inositol phosphate dephosphorylation (GO:0046855) | 2.72347360 |
| 156 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.71722272 |
| 157 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.71722272 |
| 158 | kidney morphogenesis (GO:0060993) | 2.70007711 |
| 159 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.69423927 |
| 160 | neurofilament cytoskeleton organization (GO:0060052) | 2.69340698 |
| 161 | dendritic spine organization (GO:0097061) | 2.68551028 |
| 162 | protein targeting to Golgi (GO:0000042) | 2.67981436 |
| 163 | regulation of respiratory burst (GO:0060263) | 2.66790985 |
| 164 | epithelial cell fate commitment (GO:0072148) | 2.65160947 |
| 165 | * positive regulation of hormone secretion (GO:0046887) | 2.64824195 |
| 166 | regulation of energy homeostasis (GO:2000505) | 2.62528969 |
| 167 | establishment of protein localization to Golgi (GO:0072600) | 2.62101679 |
| 168 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.58849004 |
| 169 | response to leptin (GO:0044321) | 2.57751851 |
| 170 | protein localization to cilium (GO:0061512) | 2.57412904 |
| 171 | protein localization to Golgi apparatus (GO:0034067) | 2.57219285 |
| 172 | retinal ganglion cell axon guidance (GO:0031290) | 2.56375794 |
| 173 | prepulse inhibition (GO:0060134) | 2.56315448 |
| 174 | negative regulation of dendrite development (GO:2000171) | 2.55209148 |
| 175 | glandular epithelial cell development (GO:0002068) | 2.54997142 |
| 176 | * negative regulation of acute inflammatory response (GO:0002674) | 2.54612407 |
| 177 | regulation of cilium movement (GO:0003352) | 2.54575245 |
| 178 | nonmotile primary cilium assembly (GO:0035058) | 2.54032705 |
| 179 | * regulation of hormone secretion (GO:0046883) | 2.52674445 |
| 180 | neuron maturation (GO:0042551) | 2.51768144 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.40430147 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.37726901 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.63988413 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.19423370 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.08237364 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.96947352 |
| 7 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.93805756 |
| 8 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.81179367 |
| 9 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.68439317 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.66183890 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.65780358 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.63904028 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.61639995 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.61639995 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.57854501 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.55229354 |
| 17 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.52391710 |
| 18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.49426686 |
| 19 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.49204874 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.47973363 |
| 21 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.42960220 |
| 22 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.36141301 |
| 23 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.31567115 |
| 24 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.22352018 |
| 25 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.21493874 |
| 26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.20683126 |
| 27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.06892753 |
| 28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.02299126 |
| 29 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.00877478 |
| 30 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.99170773 |
| 31 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.94577438 |
| 32 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.92761447 |
| 33 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.81501264 |
| 34 | * AR_21572438_ChIP-Seq_LNCaP_Human | 1.79761251 |
| 35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.78927508 |
| 36 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.69587872 |
| 37 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.69001026 |
| 38 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.64038559 |
| 39 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.62284439 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.58037342 |
| 41 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.50912073 |
| 42 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.50641022 |
| 43 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.47612369 |
| 44 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.44361584 |
| 45 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.40576906 |
| 46 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.39967420 |
| 47 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.38832047 |
| 48 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.38151096 |
| 49 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.36611625 |
| 50 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.35554945 |
| 51 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.35413493 |
| 52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.34989931 |
| 53 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34976414 |
| 54 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.31973310 |
| 55 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.29688332 |
| 56 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28337016 |
| 57 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.28050007 |
| 58 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.26851678 |
| 59 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26835167 |
| 60 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.26465176 |
| 61 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26004137 |
| 62 | AR_25329375_ChIP-Seq_VCAP_Human | 1.25538157 |
| 63 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.25056932 |
| 64 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.22468548 |
| 65 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.21993438 |
| 66 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.21993438 |
| 67 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.16917151 |
| 68 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.16809819 |
| 69 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.16759613 |
| 70 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.15947803 |
| 71 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.15083806 |
| 72 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.15051317 |
| 73 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.13812836 |
| 74 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.13552758 |
| 75 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.12591174 |
| 76 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.12505789 |
| 77 | EWS_26573619_Chip-Seq_HEK293_Human | 1.12294597 |
| 78 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.12166320 |
| 79 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.11143138 |
| 80 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.10502032 |
| 81 | STAT3_23295773_ChIP-Seq_U87_Human | 1.10229717 |
| 82 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09890018 |
| 83 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08988367 |
| 84 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.08900051 |
| 85 | FUS_26573619_Chip-Seq_HEK293_Human | 1.08655580 |
| 86 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08610198 |
| 87 | AR_19668381_ChIP-Seq_PC3_Human | 1.08479588 |
| 88 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07128435 |
| 89 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.06742047 |
| 90 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.06695506 |
| 91 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06290038 |
| 92 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06255341 |
| 93 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.05569900 |
| 94 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.05519537 |
| 95 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.04903974 |
| 96 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.04549336 |
| 97 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02571523 |
| 98 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.02053501 |
| 99 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.02014128 |
| 100 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.01852444 |
| 101 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01311933 |
| 102 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01266325 |
| 103 | TCF4_23295773_ChIP-Seq_U87_Human | 1.00893849 |
| 104 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.00881675 |
| 105 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.00642073 |
| 106 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.00441882 |
| 107 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.00101891 |
| 108 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.99937745 |
| 109 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.98716933 |
| 110 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.98689071 |
| 111 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.98613447 |
| 112 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.97987328 |
| 113 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.97504215 |
| 114 | JUN_21703547_ChIP-Seq_K562_Human | 0.94194613 |
| 115 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.92359863 |
| 116 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92359863 |
| 117 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.90459733 |
| 118 | VDR_22108803_ChIP-Seq_LS180_Human | 0.90428024 |
| 119 | KDM2B_26808549_Chip-Seq_REH_Human | 0.87468566 |
| 120 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.87369130 |
| 121 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.86999682 |
| 122 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86155887 |
| 123 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.85563359 |
| 124 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.83668204 |
| 125 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.83582848 |
| 126 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.83523511 |
| 127 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.83506474 |
| 128 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.82253529 |
| 129 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.82218667 |
| 130 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.82052186 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.33823221 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.75280004 |
| 3 | MP0001968_abnormal_touch/_nociception | 4.12145018 |
| 4 | MP0004270_analgesia | 3.81616358 |
| 5 | MP0006276_abnormal_autonomic_nervous | 3.79026241 |
| 6 | MP0002735_abnormal_chemical_nociception | 3.76256778 |
| 7 | MP0003635_abnormal_synaptic_transmissio | 3.55683749 |
| 8 | MP0003283_abnormal_digestive_organ | 3.43982080 |
| 9 | MP0002734_abnormal_mechanical_nocicepti | 3.12457808 |
| 10 | MP0009745_abnormal_behavioral_response | 3.03695356 |
| 11 | MP0003195_calcinosis | 3.01753159 |
| 12 | MP0002736_abnormal_nociception_after | 2.97709779 |
| 13 | * MP0002063_abnormal_learning/memory/cond | 2.90733872 |
| 14 | MP0009046_muscle_twitch | 2.77565988 |
| 15 | MP0005423_abnormal_somatic_nervous | 2.71353656 |
| 16 | MP0002064_seizures | 2.69568292 |
| 17 | MP0010386_abnormal_urinary_bladder | 2.67060909 |
| 18 | MP0002733_abnormal_thermal_nociception | 2.57402564 |
| 19 | * MP0002572_abnormal_emotion/affect_behav | 2.56738798 |
| 20 | MP0001970_abnormal_pain_threshold | 2.51459319 |
| 21 | MP0010234_abnormal_vibrissa_follicle | 2.48229677 |
| 22 | MP0008877_abnormal_DNA_methylation | 2.44348610 |
| 23 | MP0003122_maternal_imprinting | 2.43343786 |
| 24 | MP0002272_abnormal_nervous_system | 2.30720014 |
| 25 | * MP0001440_abnormal_grooming_behavior | 2.30536105 |
| 26 | MP0001486_abnormal_startle_reflex | 2.29977762 |
| 27 | MP0002067_abnormal_sensory_capabilities | 2.15043558 |
| 28 | MP0002638_abnormal_pupillary_reflex | 2.11832614 |
| 29 | MP0002184_abnormal_innervation | 2.10789802 |
| 30 | MP0000778_abnormal_nervous_system | 2.10719566 |
| 31 | MP0004858_abnormal_nervous_system | 2.09163054 |
| 32 | MP0001944_abnormal_pancreas_morphology | 2.08424783 |
| 33 | MP0002693_abnormal_pancreas_physiology | 1.93582450 |
| 34 | MP0005386_behavior/neurological_phenoty | 1.90832198 |
| 35 | MP0004924_abnormal_behavior | 1.90832198 |
| 36 | MP0001501_abnormal_sleep_pattern | 1.89083628 |
| 37 | MP0002928_abnormal_bile_duct | 1.83037012 |
| 38 | MP0002102_abnormal_ear_morphology | 1.80638794 |
| 39 | MP0001529_abnormal_vocalization | 1.79128455 |
| 40 | MP0003329_amyloid_beta_deposits | 1.74719139 |
| 41 | * MP0002557_abnormal_social/conspecific_i | 1.68189893 |
| 42 | MP0004811_abnormal_neuron_physiology | 1.62220842 |
| 43 | MP0009780_abnormal_chondrocyte_physiolo | 1.58916544 |
| 44 | MP0005220_abnormal_exocrine_pancreas | 1.53358603 |
| 45 | MP0004142_abnormal_muscle_tone | 1.51570571 |
| 46 | MP0003011_delayed_dark_adaptation | 1.51474041 |
| 47 | MP0001986_abnormal_taste_sensitivity | 1.49079999 |
| 48 | MP0004145_abnormal_muscle_electrophysio | 1.46624574 |
| 49 | MP0001984_abnormal_olfaction | 1.46303632 |
| 50 | MP0001905_abnormal_dopamine_level | 1.45576333 |
| 51 | MP0000955_abnormal_spinal_cord | 1.45222980 |
| 52 | MP0002909_abnormal_adrenal_gland | 1.42364978 |
| 53 | MP0002882_abnormal_neuron_morphology | 1.42129108 |
| 54 | MP0001502_abnormal_circadian_rhythm | 1.41571311 |
| 55 | MP0005645_abnormal_hypothalamus_physiol | 1.39734082 |
| 56 | MP0005646_abnormal_pituitary_gland | 1.35614279 |
| 57 | MP0000751_myopathy | 1.33388845 |
| 58 | * MP0002066_abnormal_motor_capabilities/c | 1.32923294 |
| 59 | MP0008569_lethality_at_weaning | 1.30190117 |
| 60 | MP0004742_abnormal_vestibular_system | 1.26752926 |
| 61 | MP0002078_abnormal_glucose_homeostasis | 1.26609164 |
| 62 | MP0003879_abnormal_hair_cell | 1.21002210 |
| 63 | MP0002837_dystrophic_cardiac_calcinosis | 1.19936708 |
| 64 | MP0000427_abnormal_hair_cycle | 1.19136563 |
| 65 | MP0000462_abnormal_digestive_system | 1.13261757 |
| 66 | MP0005253_abnormal_eye_physiology | 1.11586088 |
| 67 | MP0000013_abnormal_adipose_tissue | 1.10543610 |
| 68 | MP0001188_hyperpigmentation | 1.10113528 |
| 69 | MP0002090_abnormal_vision | 1.08395152 |
| 70 | MP0008872_abnormal_physiological_respon | 1.06610728 |
| 71 | MP0003633_abnormal_nervous_system | 1.04299985 |
| 72 | MP0002751_abnormal_autonomic_nervous | 1.03182075 |
| 73 | MP0004043_abnormal_pH_regulation | 1.02655838 |
| 74 | MP0004134_abnormal_chest_morphology | 1.00455286 |
| 75 | MP0002152_abnormal_brain_morphology | 1.00206598 |
| 76 | MP0002229_neurodegeneration | 0.95269288 |
| 77 | MP0000516_abnormal_urinary_system | 0.93062895 |
| 78 | MP0005367_renal/urinary_system_phenotyp | 0.93062895 |
| 79 | MP0003890_abnormal_embryonic-extraembry | 0.91406406 |
| 80 | MP0002938_white_spotting | 0.91219130 |
| 81 | MP0000569_abnormal_digit_pigmentation | 0.90958055 |
| 82 | MP0003631_nervous_system_phenotype | 0.89446650 |
| 83 | MP0003787_abnormal_imprinting | 0.89064061 |
| 84 | MP0004885_abnormal_endolymph | 0.88967092 |
| 85 | MP0002752_abnormal_somatic_nervous | 0.87130012 |
| 86 | MP0002822_catalepsy | 0.86361331 |
| 87 | MP0001963_abnormal_hearing_physiology | 0.85979767 |
| 88 | MP0001756_abnormal_urination | 0.85452122 |
| 89 | MP0003121_genomic_imprinting | 0.85448341 |
| 90 | * MP0003953_abnormal_hormone_level | 0.84425802 |
| 91 | MP0002069_abnormal_eating/drinking_beha | 0.83741231 |
| 92 | MP0002160_abnormal_reproductive_system | 0.81460674 |
| 93 | MP0003119_abnormal_digestive_system | 0.80112086 |
| 94 | MP0000604_amyloidosis | 0.79926262 |
| 95 | MP0003634_abnormal_glial_cell | 0.77025297 |
| 96 | MP0004133_heterotaxia | 0.76787758 |
| 97 | MP0005551_abnormal_eye_electrophysiolog | 0.75460407 |
| 98 | MP0004085_abnormal_heartbeat | 0.74034809 |
| 99 | MP0000538_abnormal_urinary_bladder | 0.73693329 |
| 100 | MP0006072_abnormal_retinal_apoptosis | 0.72978777 |
| 101 | MP0000631_abnormal_neuroendocrine_gland | 0.72478429 |
| 102 | MP0004484_altered_response_of | 0.71659647 |
| 103 | MP0002876_abnormal_thyroid_physiology | 0.71287508 |
| 104 | MP0000639_abnormal_adrenal_gland | 0.71095933 |
| 105 | * MP0005535_abnormal_body_temperature | 0.70345513 |
| 106 | MP0005499_abnormal_olfactory_system | 0.68840666 |
| 107 | MP0005394_taste/olfaction_phenotype | 0.68840666 |
| 108 | MP0010678_abnormal_skin_adnexa | 0.68418548 |
| 109 | MP0008874_decreased_physiological_sensi | 0.67748720 |
| 110 | MP0004510_myositis | 0.67401487 |
| 111 | MP0001485_abnormal_pinna_reflex | 0.66585171 |
| 112 | MP0000003_abnormal_adipose_tissue | 0.66514473 |
| 113 | MP0005389_reproductive_system_phenotype | 0.65628246 |
| 114 | MP0001299_abnormal_eye_distance/ | 0.64978025 |
| 115 | MP0008961_abnormal_basal_metabolism | 0.63972103 |
| 116 | MP0005623_abnormal_meninges_morphology | 0.62748356 |
| 117 | MP0001348_abnormal_lacrimal_gland | 0.61583108 |
| 118 | MP0003137_abnormal_impulse_conducting | 0.61513807 |
| 119 | MP0002163_abnormal_gland_morphology | 0.60784311 |
| 120 | MP0003632_abnormal_nervous_system | 0.59845735 |
| 121 | MP0001943_abnormal_respiration | 0.59432628 |
| 122 | MP0000026_abnormal_inner_ear | 0.58879762 |
| 123 | MP0005448_abnormal_energy_balance | 0.58591848 |
| 124 | MP0001664_abnormal_digestion | 0.57098031 |
| 125 | MP0000920_abnormal_myelination | 0.55545820 |
| 126 | MP0003861_abnormal_nervous_system | 0.54789716 |
| 127 | MP0003123_paternal_imprinting | 0.53891601 |
| 128 | MP0009379_abnormal_foot_pigmentation | 0.53883922 |
| 129 | MP0005410_abnormal_fertilization | 0.52826670 |
| 130 | MP0006035_abnormal_mitochondrial_morpho | 0.51800006 |
| 131 | MP0004233_abnormal_muscle_weight | 0.49580458 |
| 132 | MP0003183_abnormal_peptide_metabolism | 0.49369199 |
| 133 | MP0005379_endocrine/exocrine_gland_phen | 0.49239487 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic seizures (HP:0002173) | 8.15394711 |
| 2 | Hyperinsulinemic hypoglycemia (HP:0000825) | 7.45231851 |
| 3 | Focal motor seizures (HP:0011153) | 6.71470358 |
| 4 | Hypoglycemic coma (HP:0001325) | 6.69488171 |
| 5 | Myokymia (HP:0002411) | 6.08661060 |
| 6 | Ketoacidosis (HP:0001993) | 5.91976682 |
| 7 | Abnormality of endocrine pancreas physiology (HP:0012093) | 5.50718431 |
| 8 | Abnormality of the pancreatic islet cells (HP:0006476) | 5.50718431 |
| 9 | Focal seizures (HP:0007359) | 5.29999463 |
| 10 | Symptomatic seizures (HP:0011145) | 5.14668849 |
| 11 | Visual hallucinations (HP:0002367) | 4.94877717 |
| 12 | Hyperglycemia (HP:0003074) | 4.78872226 |
| 13 | Epileptic encephalopathy (HP:0200134) | 4.70297371 |
| 14 | Prominent metopic ridge (HP:0005487) | 4.63168313 |
| 15 | Atonic seizures (HP:0010819) | 4.55807381 |
| 16 | Abnormal pancreas size (HP:0012094) | 4.27173229 |
| 17 | Progressive cerebellar ataxia (HP:0002073) | 4.26685822 |
| 18 | Abnormality of the metopic suture (HP:0005556) | 4.20624344 |
| 19 | Absence seizures (HP:0002121) | 4.20076591 |
| 20 | Supranuclear gaze palsy (HP:0000605) | 4.07121555 |
| 21 | Neoplasm of the adrenal cortex (HP:0100641) | 4.05625657 |
| 22 | Polyphagia (HP:0002591) | 3.91684999 |
| 23 | Abnormal eating behavior (HP:0100738) | 3.89558505 |
| 24 | Dialeptic seizures (HP:0011146) | 3.87846018 |
| 25 | Febrile seizures (HP:0002373) | 3.85837467 |
| 26 | Generalized tonic-clonic seizures (HP:0002069) | 3.76937244 |
| 27 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.65346749 |
| 28 | Ketosis (HP:0001946) | 3.65128428 |
| 29 | Large for gestational age (HP:0001520) | 3.64068215 |
| 30 | Mutism (HP:0002300) | 3.59454371 |
| 31 | Termporal pattern (HP:0011008) | 3.56499181 |
| 32 | Insidious onset (HP:0003587) | 3.56499181 |
| 33 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.55070142 |
| 34 | Failure to thrive in infancy (HP:0001531) | 3.53211520 |
| 35 | Broad-based gait (HP:0002136) | 3.45898306 |
| 36 | Limb dystonia (HP:0002451) | 3.43461409 |
| 37 | Agitation (HP:0000713) | 3.39394263 |
| 38 | Enlarged penis (HP:0000040) | 3.34884034 |
| 39 | Action tremor (HP:0002345) | 3.31689507 |
| 40 | Late onset (HP:0003584) | 3.31058896 |
| 41 | Papilledema (HP:0001085) | 3.29097195 |
| 42 | Ankle clonus (HP:0011448) | 3.25011520 |
| 43 | Abnormality of the corticospinal tract (HP:0002492) | 3.16285470 |
| 44 | Pheochromocytoma (HP:0002666) | 3.14822605 |
| 45 | Hypomagnesemia (HP:0002917) | 3.12594195 |
| 46 | Truncal ataxia (HP:0002078) | 3.10241391 |
| 47 | Hyperventilation (HP:0002883) | 3.08605556 |
| 48 | Hepatoblastoma (HP:0002884) | 3.04401925 |
| 49 | Hypoventilation (HP:0002791) | 2.98451588 |
| 50 | Hypothermia (HP:0002045) | 2.94645417 |
| 51 | Excessive salivation (HP:0003781) | 2.93650651 |
| 52 | Drooling (HP:0002307) | 2.93650651 |
| 53 | Progressive inability to walk (HP:0002505) | 2.91859550 |
| 54 | Amblyopia (HP:0000646) | 2.85070979 |
| 55 | Neuroendocrine neoplasm (HP:0100634) | 2.84079313 |
| 56 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.83706641 |
| 57 | Neurofibrillary tangles (HP:0002185) | 2.76850366 |
| 58 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.75780367 |
| 59 | Urinary urgency (HP:0000012) | 2.74704994 |
| 60 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.72300828 |
| 61 | Metaphyseal dysplasia (HP:0100255) | 2.72140700 |
| 62 | Depression (HP:0000716) | 2.70662913 |
| 63 | Poor eye contact (HP:0000817) | 2.69280391 |
| 64 | Increased circulating renin level (HP:0000848) | 2.67998269 |
| 65 | Type I diabetes mellitus (HP:0100651) | 2.65462697 |
| 66 | Abnormal hair whorl (HP:0010721) | 2.62711556 |
| 67 | Anxiety (HP:0000739) | 2.62454771 |
| 68 | Cerebral inclusion bodies (HP:0100314) | 2.61878633 |
| 69 | Abnormality of magnesium homeostasis (HP:0004921) | 2.59589711 |
| 70 | Sleep apnea (HP:0010535) | 2.58145211 |
| 71 | Inability to walk (HP:0002540) | 2.54909407 |
| 72 | Gait imbalance (HP:0002141) | 2.53529466 |
| 73 | Muscular hypotonia of the trunk (HP:0008936) | 2.52182941 |
| 74 | Calf muscle hypertrophy (HP:0008981) | 2.51941341 |
| 75 | Spastic gait (HP:0002064) | 2.45169228 |
| 76 | Gaze-evoked nystagmus (HP:0000640) | 2.44761981 |
| 77 | Ulnar claw (HP:0001178) | 2.43605366 |
| 78 | Esotropia (HP:0000565) | 2.41904487 |
| 79 | Fetal akinesia sequence (HP:0001989) | 2.35651345 |
| 80 | Impaired social interactions (HP:0000735) | 2.35328643 |
| 81 | Abnormal social behavior (HP:0012433) | 2.35328643 |
| 82 | Neoplasm of the adrenal gland (HP:0100631) | 2.34619416 |
| 83 | Dysdiadochokinesis (HP:0002075) | 2.34286385 |
| 84 | Abnormality of pain sensation (HP:0010832) | 2.33493352 |
| 85 | Impaired pain sensation (HP:0007328) | 2.33493352 |
| 86 | Amyotrophic lateral sclerosis (HP:0007354) | 2.33315988 |
| 87 | Dysmetria (HP:0001310) | 2.31093757 |
| 88 | Specific learning disability (HP:0001328) | 2.28779392 |
| 89 | Epileptiform EEG discharges (HP:0011182) | 2.28209357 |
| 90 | Abnormality of the labia minora (HP:0012880) | 2.27454085 |
| 91 | Poor suck (HP:0002033) | 2.27370451 |
| 92 | Hemiparesis (HP:0001269) | 2.27156099 |
| 93 | Downturned corners of mouth (HP:0002714) | 2.26908489 |
| 94 | EEG with generalized epileptiform discharges (HP:0011198) | 2.24604692 |
| 95 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.23791970 |
| 96 | Abnormal drinking behavior (HP:0030082) | 2.23590334 |
| 97 | Polydipsia (HP:0001959) | 2.23590334 |
| 98 | Lower limb muscle weakness (HP:0007340) | 2.22739728 |
| 99 | Hyperphosphatemia (HP:0002905) | 2.20437834 |
| 100 | Genetic anticipation (HP:0003743) | 2.18908180 |
| 101 | Akinesia (HP:0002304) | 2.18763492 |
| 102 | Abnormality of the lower motor neuron (HP:0002366) | 2.18160453 |
| 103 | Macroorchidism (HP:0000053) | 2.18153606 |
| 104 | Diplopia (HP:0000651) | 2.17887090 |
| 105 | Abnormality of binocular vision (HP:0011514) | 2.17887090 |
| 106 | Bradykinesia (HP:0002067) | 2.17861941 |
| 107 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.16532184 |
| 108 | Exotropia (HP:0000577) | 2.15234341 |
| 109 | Hypsarrhythmia (HP:0002521) | 2.12107078 |
| 110 | Psychosis (HP:0000709) | 2.10202301 |
| 111 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.10134008 |
| 112 | Hypoplasia of the brainstem (HP:0002365) | 2.10134008 |
| 113 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.08136038 |
| 114 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.08136038 |
| 115 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.08002996 |
| 116 | Scanning speech (HP:0002168) | 2.07748724 |
| 117 | Postural instability (HP:0002172) | 2.06680970 |
| 118 | Lissencephaly (HP:0001339) | 2.05565907 |
| 119 | Hamartoma of the eye (HP:0010568) | 2.05316177 |
| 120 | Myotonia (HP:0002486) | 2.04953941 |
| 121 | Oligomenorrhea (HP:0000876) | 2.04650495 |
| 122 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.02742164 |
| 123 | Testicular neoplasm (HP:0010788) | 2.00812158 |
| 124 | Torticollis (HP:0000473) | 2.00101531 |
| 125 | Progressive macrocephaly (HP:0004481) | 1.99530199 |
| 126 | Nephrogenic diabetes insipidus (HP:0009806) | 1.99012580 |
| 127 | Ventricular fibrillation (HP:0001663) | 1.97628067 |
| 128 | Neonatal hypoglycemia (HP:0001998) | 1.97080487 |
| 129 | Hyperthyroidism (HP:0000836) | 1.97005137 |
| 130 | Narrow nasal bridge (HP:0000446) | 1.96273018 |
| 131 | Hepatic necrosis (HP:0002605) | 1.95891375 |
| 132 | Impaired smooth pursuit (HP:0007772) | 1.94881696 |
| 133 | Protruding tongue (HP:0010808) | 1.93520682 |
| 134 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.90179995 |
| 135 | Blue irides (HP:0000635) | 1.88153070 |
| 136 | Abnormality of salivation (HP:0100755) | 1.88026948 |
| 137 | Delusions (HP:0000746) | 1.87914618 |
| 138 | Nephronophthisis (HP:0000090) | 1.87364037 |
| 139 | Generalized myoclonic seizures (HP:0002123) | 1.86653012 |
| 140 | Menstrual irregularities (HP:0000858) | 1.86496089 |
| 141 | Lower limb amyotrophy (HP:0007210) | 1.85763082 |
| 142 | Focal dystonia (HP:0004373) | 1.85477681 |
| 143 | Medial flaring of the eyebrow (HP:0010747) | 1.85303391 |
| 144 | Congenital primary aphakia (HP:0007707) | 1.85110147 |
| 145 | Difficulty running (HP:0009046) | 1.85006363 |
| 146 | Aqueductal stenosis (HP:0002410) | 1.81770057 |
| 147 | Genital tract atresia (HP:0001827) | 1.73914401 |
| 148 | Vaginal atresia (HP:0000148) | 1.73427225 |
| 149 | Hematochezia (HP:0002573) | 1.73380180 |
| 150 | Adrenal hypoplasia (HP:0000835) | 1.73295884 |
| 151 | Intention tremor (HP:0002080) | 1.71760281 |
| 152 | Insulin resistance (HP:0000855) | 1.70248150 |
| 153 | Methylmalonic acidemia (HP:0002912) | 1.69883818 |
| 154 | Abnormality of the renal cortex (HP:0011035) | 1.67306100 |
| 155 | Hypogonadotrophic hypogonadism (HP:0000044) | 1.67187969 |
| 156 | Status epilepticus (HP:0002133) | 1.65022067 |
| 157 | Abnormal sex determination (HP:0012244) | 1.64948456 |
| 158 | Sex reversal (HP:0012245) | 1.64948456 |
| 159 | Restlessness (HP:0000711) | 1.63190674 |
| 160 | Conjunctival hamartoma (HP:0100780) | 1.63161601 |
| 161 | Abnormality of renin-angiotensin system (HP:0000847) | 1.62895955 |
| 162 | Molar tooth sign on MRI (HP:0002419) | 1.62433732 |
| 163 | Abnormality of midbrain morphology (HP:0002418) | 1.62433732 |
| 164 | Abnormality of the renal medulla (HP:0100957) | 1.60653507 |
| 165 | Pancreatic fibrosis (HP:0100732) | 1.58729690 |
| 166 | Hypokinesia (HP:0002375) | 1.56055489 |
| 167 | Asymmetry of the thorax (HP:0001555) | 1.55081705 |
| 168 | Increased density of long bones (HP:0006392) | 1.54380175 |
| 169 | Thyroid carcinoma (HP:0002890) | 1.49497537 |
| 170 | Tachypnea (HP:0002789) | 1.49445916 |
| 171 | Poor coordination (HP:0002370) | 1.49138651 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 7.51152174 |
| 2 | MAP3K9 | 4.40398305 |
| 3 | MARK1 | 4.39412125 |
| 4 | NTRK3 | 3.76967334 |
| 5 | PASK | 3.34282821 |
| 6 | MAP3K12 | 3.21688690 |
| 7 | CASK | 3.20324165 |
| 8 | MINK1 | 2.93306833 |
| 9 | MAP3K4 | 2.85039750 |
| 10 | NTRK2 | 2.46590964 |
| 11 | MAP2K7 | 2.46429163 |
| 12 | NTRK1 | 2.39265508 |
| 13 | EPHA4 | 2.31951722 |
| 14 | TRIM28 | 2.29823405 |
| 15 | DAPK2 | 2.12051459 |
| 16 | MAP2K4 | 2.10029625 |
| 17 | PAK6 | 1.88866955 |
| 18 | MAPK13 | 1.82073317 |
| 19 | SIK2 | 1.79637039 |
| 20 | KSR2 | 1.79521672 |
| 21 | UHMK1 | 1.79326215 |
| 22 | CDK19 | 1.68019114 |
| 23 | SIK3 | 1.57511477 |
| 24 | KSR1 | 1.53404643 |
| 25 | PINK1 | 1.53392568 |
| 26 | LATS2 | 1.51238302 |
| 27 | TNIK | 1.46302171 |
| 28 | GRK5 | 1.46123941 |
| 29 | PNCK | 1.45956762 |
| 30 | PHKG2 | 1.44907528 |
| 31 | PHKG1 | 1.44907528 |
| 32 | CDK5 | 1.43573124 |
| 33 | BCR | 1.42747401 |
| 34 | FGFR3 | 1.38828159 |
| 35 | ADRBK2 | 1.35486926 |
| 36 | DAPK1 | 1.27571651 |
| 37 | LIMK1 | 1.21481248 |
| 38 | PLK2 | 1.15574903 |
| 39 | HIPK2 | 1.13976666 |
| 40 | WNK4 | 1.12690996 |
| 41 | RIPK4 | 1.09285474 |
| 42 | MAP3K2 | 1.03310011 |
| 43 | RET | 1.03158053 |
| 44 | PRKCG | 1.02874361 |
| 45 | CDK18 | 1.01978910 |
| 46 | PAK3 | 1.01259251 |
| 47 | NLK | 1.01050749 |
| 48 | GRK1 | 1.00753050 |
| 49 | CSNK1G1 | 1.00595853 |
| 50 | INSRR | 1.00309805 |
| 51 | CSNK1G2 | 0.99602290 |
| 52 | CDK14 | 0.99407923 |
| 53 | ARAF | 0.98616833 |
| 54 | CCNB1 | 0.97861334 |
| 55 | CAMK2A | 0.96185719 |
| 56 | ACVR1B | 0.94555853 |
| 57 | CDK15 | 0.93082437 |
| 58 | LMTK2 | 0.92625242 |
| 59 | SGK3 | 0.92150265 |
| 60 | DYRK2 | 0.91843012 |
| 61 | PRKAA1 | 0.91496616 |
| 62 | WNK3 | 0.90638954 |
| 63 | PRKAA2 | 0.89937829 |
| 64 | ZAK | 0.87976116 |
| 65 | STK39 | 0.87579423 |
| 66 | CAMKK1 | 0.86718077 |
| 67 | TYRO3 | 0.86027672 |
| 68 | FGFR2 | 0.83751184 |
| 69 | OXSR1 | 0.83310112 |
| 70 | AKT3 | 0.81451006 |
| 71 | STK38L | 0.81187102 |
| 72 | FER | 0.80888826 |
| 73 | CDK11A | 0.79791035 |
| 74 | PRPF4B | 0.79299379 |
| 75 | STK38 | 0.76377367 |
| 76 | MAP4K2 | 0.73968453 |
| 77 | NUAK1 | 0.72936195 |
| 78 | EPHB2 | 0.72876510 |
| 79 | GRK7 | 0.71817605 |
| 80 | FES | 0.68599891 |
| 81 | CSNK1G3 | 0.68299269 |
| 82 | CAMKK2 | 0.67615658 |
| 83 | CDK3 | 0.67594997 |
| 84 | PRKCE | 0.64701481 |
| 85 | ADRBK1 | 0.62892250 |
| 86 | CAMK2B | 0.61349392 |
| 87 | DYRK1A | 0.60510843 |
| 88 | SGK223 | 0.60225530 |
| 89 | SGK494 | 0.60225530 |
| 90 | TAOK1 | 0.58171356 |
| 91 | STK16 | 0.57481610 |
| 92 | ERBB3 | 0.57213573 |
| 93 | MARK2 | 0.56425523 |
| 94 | STK11 | 0.56084292 |
| 95 | SCYL2 | 0.55544826 |
| 96 | TNK2 | 0.55312313 |
| 97 | BMPR1B | 0.53519725 |
| 98 | PRKCZ | 0.51389544 |
| 99 | RPS6KA2 | 0.49489321 |
| 100 | MAP3K1 | 0.49230421 |
| 101 | STK24 | 0.49190298 |
| 102 | EPHA3 | 0.49004824 |
| 103 | CAMK1G | 0.48024119 |
| 104 | CSNK1E | 0.45654169 |
| 105 | CAMK1D | 0.44520722 |
| 106 | CAMK2D | 0.43677097 |
| 107 | MAP3K7 | 0.43549592 |
| 108 | ROCK2 | 0.43468351 |
| 109 | STK3 | 0.43000180 |
| 110 | NME1 | 0.42843086 |
| 111 | MAP2K6 | 0.42842965 |
| 112 | MAPK15 | 0.42081444 |
| 113 | CAMK1 | 0.41732122 |
| 114 | FYN | 0.41381537 |
| 115 | MAPK12 | 0.40402786 |
| 116 | DAPK3 | 0.39775526 |
| 117 | PRKG1 | 0.39386583 |
| 118 | PRKD3 | 0.39094193 |
| 119 | CSNK1A1L | 0.36968173 |
| 120 | CSNK1A1 | 0.36717592 |
| 121 | MAP2K1 | 0.36172968 |
| 122 | PRKCH | 0.34083169 |
| 123 | CAMK2G | 0.33299676 |
| 124 | CDC42BPA | 0.33151945 |
| 125 | PRKCA | 0.33101099 |
| 126 | MKNK2 | 0.33051544 |
| 127 | DYRK3 | 0.32292793 |
| 128 | SGK2 | 0.32218663 |
| 129 | WNK1 | 0.31572800 |
| 130 | CSNK1D | 0.31547436 |
| 131 | PTK2B | 0.30847005 |
| 132 | MATK | 0.30707965 |
| 133 | SGK1 | 0.30196080 |
| 134 | FGR | 0.30063555 |
| 135 | PLK3 | 0.29954759 |
| 136 | RPS6KA3 | 0.29734297 |
| 137 | MAPK10 | 0.29097477 |
| 138 | MAPK4 | 0.28748510 |
| 139 | TRPM7 | 0.28564701 |
| 140 | IRAK1 | 0.28344949 |
| 141 | PRKACA | 0.28280715 |
| 142 | MAP3K13 | 0.28165639 |
| 143 | MAP3K11 | 0.27577283 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 7.38908861 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.98510325 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.70911422 |
| 4 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.78329015 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.62408208 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.61296421 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.43549880 |
| 8 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.34968560 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.30355144 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.29488740 |
| 11 | Circadian entrainment_Homo sapiens_hsa04713 | 2.28135189 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.26252977 |
| 13 | Long-term potentiation_Homo sapiens_hsa04720 | 2.20695924 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.20468868 |
| 15 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.12879416 |
| 16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.08384682 |
| 17 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.07121908 |
| 18 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.98095219 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.95469217 |
| 20 | * Insulin secretion_Homo sapiens_hsa04911 | 1.81929416 |
| 21 | Salivary secretion_Homo sapiens_hsa04970 | 1.79437443 |
| 22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.79265002 |
| 23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.76925385 |
| 24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.73020356 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.72394553 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.61466072 |
| 27 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.61374533 |
| 28 | Long-term depression_Homo sapiens_hsa04730 | 1.59977813 |
| 29 | Axon guidance_Homo sapiens_hsa04360 | 1.56420386 |
| 30 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.55440994 |
| 31 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.52842008 |
| 32 | * Renin secretion_Homo sapiens_hsa04924 | 1.47878561 |
| 33 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.44691393 |
| 34 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.43446490 |
| 35 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.41535373 |
| 36 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.41262569 |
| 37 | Gap junction_Homo sapiens_hsa04540 | 1.38773155 |
| 38 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.33166897 |
| 39 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.28729725 |
| 40 | Parkinsons disease_Homo sapiens_hsa05012 | 1.28562052 |
| 41 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.25623761 |
| 42 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.23167988 |
| 43 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.22608117 |
| 44 | Alzheimers disease_Homo sapiens_hsa05010 | 1.20732868 |
| 45 | Circadian rhythm_Homo sapiens_hsa04710 | 1.16751110 |
| 46 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.16749517 |
| 47 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.15610335 |
| 48 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.15458805 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14619609 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.09999167 |
| 51 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.09247809 |
| 52 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.08888118 |
| 53 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.07770449 |
| 54 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.07420452 |
| 55 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.02442372 |
| 56 | Melanogenesis_Homo sapiens_hsa04916 | 1.00845407 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00352132 |
| 58 | Glioma_Homo sapiens_hsa05214 | 1.00124128 |
| 59 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.96364945 |
| 60 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.95436079 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93400861 |
| 62 | Huntingtons disease_Homo sapiens_hsa05016 | 0.90560297 |
| 63 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.88534639 |
| 64 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.88358938 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81416685 |
| 66 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.81033023 |
| 67 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.78225455 |
| 68 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76420928 |
| 69 | Phototransduction_Homo sapiens_hsa04744 | 0.75072749 |
| 70 | Peroxisome_Homo sapiens_hsa04146 | 0.73468388 |
| 71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72666190 |
| 72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.71579575 |
| 73 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.71393614 |
| 74 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.69074919 |
| 75 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.68257925 |
| 76 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.66836687 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66651109 |
| 78 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.66316293 |
| 79 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.65628928 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.65487111 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64886551 |
| 82 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62170097 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60891717 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60752615 |
| 85 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59474371 |
| 86 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.59125128 |
| 87 | ABC transporters_Homo sapiens_hsa02010 | 0.57630078 |
| 88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57094794 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56952138 |
| 90 | Alcoholism_Homo sapiens_hsa05034 | 0.56340670 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56331746 |
| 92 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.53522612 |
| 93 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.53395578 |
| 94 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.52319557 |
| 95 | Phagosome_Homo sapiens_hsa04145 | 0.52105290 |
| 96 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.51998507 |
| 97 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51592445 |
| 98 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.51581821 |
| 99 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.50694629 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | 0.50592213 |
| 101 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50517747 |
| 102 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.50446683 |
| 103 | Insulin resistance_Homo sapiens_hsa04931 | 0.49977080 |
| 104 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.48906073 |
| 105 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.48124820 |
| 106 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.47557015 |
| 107 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47137797 |
| 108 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.45427597 |
| 109 | Bile secretion_Homo sapiens_hsa04976 | 0.44267290 |
| 110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43598608 |
| 111 | Endocytosis_Homo sapiens_hsa04144 | 0.43539784 |
| 112 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.43074937 |
| 113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.41282759 |
| 114 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38948988 |
| 115 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.38038610 |
| 116 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.36769961 |
| 117 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.35728424 |
| 118 | Colorectal cancer_Homo sapiens_hsa05210 | 0.35148696 |
| 119 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.33392311 |
| 120 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.33186610 |
| 121 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.32925835 |
| 122 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.32862092 |
| 123 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.32640300 |
| 124 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.32003998 |
| 125 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31909746 |
| 126 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.31633070 |
| 127 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.30899587 |
| 128 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.30584103 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30413377 |
| 130 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.29809143 |
| 131 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.29747493 |
| 132 | Melanoma_Homo sapiens_hsa05218 | 0.26893095 |
| 133 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.26424833 |
| 134 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.25674623 |
| 135 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.24997387 |

